Fayez Sarofim & Co’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$101K Sell
16,797
-400
-2% -$3.01K ﹤0.01% 294
2025
Q4
$123K Sell
17,197
-2,500
-13% -$19.8K ﹤0.01% 296
2025
Q3
$210K Sell
19,697
-1,481
-7% -$14.5K ﹤0.01% 296
2025
Q2
$205K Sell
21,178
-130
-0.6% -$1.34K ﹤0.01% 301
2025
Q1
$317K Sell
21,308
-287
-1% -$4.41K ﹤0.01% 264
2024
Q4
$322K Sell
21,595
-8,204
-28% -$134K ﹤0.01% 270
2024
Q3
$570K Buy
29,799
+5,345
+22% +$111K ﹤0.01% 209
2024
Q2
$506K Buy
24,454
+4,337
+22% +$86.2K ﹤0.01% 217
2024
Q1
$378K Sell
20,117
-2,697
-12% -$46.3K ﹤0.01% 239
2023
Q4
$374K Sell
22,814
-2,167
-9% -$29.5K ﹤0.01% 238
2023
Q3
$434K Sell
24,981
-1,860
-7% -$38.8K ﹤0.01% 223
2023
Q2
$559K Sell
26,841
-140,964
-84% -$3.06M ﹤0.01% 205
2023
Q1
$3.95M Sell
167,805
-12,920
-7% -$347K 0.01% 117
2022
Q4
$5.05M Sell
180,725
-431,548
-70% -$11M 0.02% 109
2022
Q3
$14.3M Sell
612,273
-1,116,377
-65% -$33.7M 0.06% 85
2022
Q2
$58.3M Sell
1,728,650
-9,722
-0.6% -$341K 0.21% 62
2022
Q1
$60.7M Sell
1,738,372
-9,698
-0.6% -$332K 0.19% 66
2021
Q4
$53.2M Sell
1,748,070
-5,473
-0.3% -$178K 0.16% 74
2021
Q3
$57.5M Sell
1,753,543
-5,375
-0.3% -$172K 0.19% 71
2021
Q2
$53.2M Buy
+1,758,918
New +$57.9M 0.18% 69

Other funds holding OGN

Fayez Sarofim & Co's OGN Position: Q1 2026 in Review

Fayez Sarofim & Co reduced its Organon & Co (OGN) stake by 2.3% in Q1 2026, selling an estimated $3.01K and leaving 16,797 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #294.

Fayez Sarofim & Co first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $60.7M in Q1 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Fayez Sarofim & Co held 16,797 shares of Organon & Co worth $101K as of Q1 2026.
  • Fayez Sarofim & Co sold 400 Organon & Co shares in Q1 2026, an estimated $3.01K.
  • Organon & Co made up ﹤0.01% of Fayez Sarofim & Co's portfolio in Q1 2026, its #294 holding.
  • Fayez Sarofim & Co first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
  • Fayez Sarofim & Co's Organon & Co position peaked at $60.7M in Q1 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Fayez Sarofim & Co's 13F filing for Q1 2026, filed 15 May 2026.